Pharmacovigilance Programs with AI for Faster Safety Decisions

Biotech, Drug Discovery & Development, Drug Safety, Life Science, Pharma, Pharmaceutical Regulation, Pharmacovigilance,
  • Wednesday, February 11, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Safety and pharmacovigilance teams are under pressure to manage rising case volumes and evolving regulatory expectations, which can strain consistency, timeliness and oversight across pharmacovigilance programs. This webinar will explore practical applications of AI to streamline adverse event reporting, enhance event processing and improve compliance, helping teams achieve faster, more accurate safety outcomes.

Attendees will gain insights into emerging technologies, real-world use cases and strategies for integrating AI into existing workflows without compromising regulatory rigor.

The session will outline where AI can add value across the case lifecycle, how to evaluate fit-for-purpose use cases and what governance and controls support audit readiness while strengthening patient safety in 2026 and beyond.

Register for this webinar to learn how AI can strengthen pharmacovigilance programs while maintaining regulatory rigor.

Speakers

Sid Potnis, Director of Veeva Safety Strategy, Veeva Systems

Sid Potnis, Director of Veeva Safety Strategy, Veeva Systems

Sid Potnis is Director of Strategy at Veeva, focused on helping small and mid-size biopharma companies and CROs successfully adopt the Veeva Safety platform and optimize their pharmacovigilance operations. With over 15 years of experience in global PV and drug safety systems, he drives market adoption of the Veeva Safety platform and provides thought leadership on modern safety processes. Sid partners with sponsors, CROs and cross-functional teams to help customers evolve their safety processes and technology, ensure successful product adoption and achieve long-term success. He is passionate about leveraging technology, including AI, to simplify processes, enhance compliance and support patient safety.

Message Presenter
Craig McIlloney, Senior Vice President, Catalyst Flex, Catalyst Clinical Research

Craig McIlloney, Senior Vice President, Catalyst Flex, Catalyst Clinical Research

Craig brings 25 years of drug development experience at both small and large CROs to his role at Catalyst. As Senior Vice President of Catalyst Flex, Craig is responsible for the global execution of functional services across multiple therapeutic areas. In his previous roles, Craig has overseen global operations across multiple functions including but not limited to data management, biostatistics, statistical programming, medical writing, quality, analytics and systems and communications. This has included global expansion across multiple regions, and his leadership experience spans various delivery models, including FSP, full-service and hybrid. He earned a BS (Hons) degree in Statistics from the University of Glasgow, UK and an MS in Applied Statistics from Napier University, Edinburgh, UK. He is a Chartered Statistician (CStat) with the Royal Statistical Society and was previously a director of the Statisticians in the Pharmaceutical Industry (PSI).

Message Presenter
Lisa Dawson, RN, Senior Director of Safety, Catalyst Flex

Lisa Dawson, RN, Senior Director of Safety, Catalyst Flex

Lisa is a Registered Nurse with 17 years of industry experience in both pharma and CRO settings. Lisa held various roles of responsibility in pharmacovigilance management. Lisa was the Manager of Pharmacovigilance at a large global CRO, with oversight of global clinical trials across all phases; development of procedural documents; and collaboration with pharmacovigilance physicians and administrative staff, clinical project teams and Data Management to ensure compliance with company SOPs and regulatory guidelines. Before joining Catalyst, Lisa worked in the biotechnology space and with a large pharma company.

Message Presenter

Who Should Attend?

This session is designed for clinical and biometrics operational leaders, data managers and project teams involved in CRO/FSP transitions. Attendees will leave with actionable insights and tools to navigate transitions with confidence and clarity.

What You Will Learn

Attendees will learn how to:

  • Streamline Safety Workflows with AI – See how AI can simplify adverse event reporting and case processing, cutting down manual effort while boosting accuracy
  • Stay Compliant with Confidence – Discover proven strategies to integrate AI into pharmacovigilance programs without sacrificing regulatory rigor, ensuring audit readiness and global compliance
  • Explore the Future of PVG Technology – Get an inside look at emerging AI innovations and real‑world success stories from life sciences organizations already transforming their safety outcomes
  • Strengthen Patient Safety & Decision-Making – Learn how AI reduces operational burden, accelerates insights and empowers proactive risk management to protect patients in 2026 and beyond

Xtalks Partner

Catalyst Flex

Catalyst Flex, a functional service provider (FSP) solution of Catalyst Clinical Research, is a multi-therapeutic niche contract research organization (CRO) with flexible, fit-for-purpose offerings in global resourcing, functional services, and hybrid models for partners and clients in clinical operations, biometrics, medical writing, and safety services. We supply people, process, and technology solutions designed to meet each client’s unique functional needs. Catalyst’s flexible service model comes from more than a decade of listening to clients, devising solutions for them to help advance clinical studies leveraging our expert teams and innovative technologies.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account